{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:22:08Z","timestamp":1794594128218,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ijcard.2026.135007","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:13:36Z","timestamp":1792595616000},"page":"135007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial"],"prefix":"10.1016","volume":"466","author":[{"given":"Sanne","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty J.C.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.P.","family":"Luijkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.I.","family":"Woelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.M.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey H.H.","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jan M.","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Rasoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud W.J. van\u00a0't","family":"Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.135007_bb0005","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00702.2020","article-title":"Coronary heart disease and atrial fibrillation: a vicious cycle","volume":"320","author":"Liang","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2026.135007_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4330\/wjc.v15.i5.229","article-title":"Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship","volume":"15","author":"Batta","year":"2023","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.135007_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2026.135007_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","article-title":"Patients with atrial fibrillation and coronary artery disease - double trouble","volume":"63","author":"Michniewicz","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.ijcard.2026.135007_bb0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.135007_bb0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.135007_bb0035","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0040","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.135007_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.135007_bb0050","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"C","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.135007_bb0055","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.135007_bb0060","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehz059","article-title":"Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial","volume":"40","author":"Oldgren","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcin.2021.01.024","article-title":"Effect of CYP2C19 genotype on ischemic outcomes during oral P2Y(12) inhibitor therapy: a meta-analysis","volume":"14","author":"Pereira","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2026.135007_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.2870","article-title":"CYP2C19 genotype prevalence and association with recurrent myocardial infarction in British-South Asians treated with clopidogrel","volume":"44","author":"Magavern","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2022.08.001","article-title":"CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)","volume":"254","author":"Kranendonk","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/fca-2021-0085","article-title":"Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: a study rationale","volume":"18","author":"Luijkx","year":"2022","journal-title":"Futur. Cardiol."},{"key":"10.1016\/j.ijcard.2026.135007_bb0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12471-025-01934-7","article-title":"Design and rationale of the South-East Netherlands heart registry (ZON-HR)","volume":"33","author":"Woelders","year":"2025","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0090","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.135007_bb0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4244\/EIJ-D-25-01373","article-title":"Ticagrelor versus clopidogrel in orally anticoagulated patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"22","author":"Emilsson","year":"2026","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2026.135007_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40256-020-00436-8","article-title":"Meta-analysis comparing potent Oral P2Y(12) inhibitors versus clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"21","author":"Casula","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2026.135007_bb0105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.135007_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-026-04629-7","article-title":"Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial","author":"Rizas","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2026.135007_bb0115","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/eurheartj\/ehw454","article-title":"Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis","volume":"38","author":"Halvorsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.135007_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00392-018-1392-2","article-title":"Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS registry","volume":"108","author":"Moalem","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2026.135007_bb0125","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.4244\/EIJ-D-24-00100","article-title":"Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial","volume":"20","author":"Verburg","year":"2024","journal-title":"EuroIntervention"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326008570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326008570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:43:30Z","timestamp":1794591810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326008570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":25,"alternative-id":["S0167527326008570"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.135007","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.135007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"135007"}}